Association between opioid agonist therapy and testing, treatment uptake, and treatment outcomes for hepatitis C infection among people who inject drugs: a …
Background People who inject drugs (PWID) experience barriers to accessing testing and
treatment for hepatitis C virus (HCV) infection. Opioid agonist therapy (OAT) may provide an …
treatment for hepatitis C virus (HCV) infection. Opioid agonist therapy (OAT) may provide an …
[PDF][PDF] The hepatitis C epidemic in Canada: an overview of recent trends in surveillance, injection drug use, harm reduction and treatment
L Lourenço, M Kelly, J Tarasuk, K Stairs… - Canada Communicable …, 2021 - canada.ca
Hepatitis C continues to be a significant public health concern in Canada, with the hepatitis
C virus (HCV) responsible for more life-years lost than all other infectious diseases in …
C virus (HCV) responsible for more life-years lost than all other infectious diseases in …
Accessible hepatitis C care for people who inject drugs: a randomized clinical trial
B Eckhardt, P Mateu-Gelabert… - JAMA Internal …, 2022 - jamanetwork.com
Importance To achieve hepatitis C elimination, treatment programs need to engage, treat,
and cure people who inject drugs. Objective To compare a low-threshold, nonstigmatizing …
and cure people who inject drugs. Objective To compare a low-threshold, nonstigmatizing …
Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)
LT Fadnes, CF Aas, JH Vold, RA Leiva… - PLoS …, 2021 - journals.plos.org
Background The standard pathways of testing and treatment for hepatitis C virus (HCV)
infection in tertiary healthcare are not easily accessed by people who inject drugs (PWID) …
infection in tertiary healthcare are not easily accessed by people who inject drugs (PWID) …
Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: the ETHOS Engage Study
Background Evaluating progress towards hepatitis C virus (HCV) elimination is critical. This
study estimated prevalence of current HCV infection and HCV treatment uptake among …
study estimated prevalence of current HCV infection and HCV treatment uptake among …
Age and gender-specific hepatitis C continuum of care and predictors of direct acting antiviral treatment among persons who inject drugs in Seattle, Washington
MA Corcorran, JI Tsui, JD Scott, JC Dombrowski… - Drug and alcohol …, 2021 - Elsevier
Abstract Background Direct acting antivirals (DAAs) have revolutionized management of
hepatitis C virus (HCV), but treatment uptake remains low among persons who inject drugs …
hepatitis C virus (HCV), but treatment uptake remains low among persons who inject drugs …
Rapid hepatitis C virus point-of-care RNA testing and treatment at an integrated supervised consumption service in Toronto, Canada: a prospective, observational …
B Lettner, K Mason, ZR Greenwald, J Broad… - The Lancet Regional …, 2023 - thelancet.com
Background Despite high burden of Hepatitis C (HCV) among people who inject drugs,
significant barriers to care persist. The aim of this study was to evaluate the provision of …
significant barriers to care persist. The aim of this study was to evaluate the provision of …
Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore
O Falade-Nwulia, R Irvin, A Merkow… - Journal of substance …, 2019 - Elsevier
Abstract Background Hepatitis C virus (HCV) infection is a major public health issue among
people who inject drugs (PWID) with prevalence of 50–80% in the United States. Effective …
people who inject drugs (PWID) with prevalence of 50–80% in the United States. Effective …
Peer-assisted telemedicine for hepatitis C in people who use drugs: A randomized controlled trial
A Seaman, R Cook, G Leichtling… - Clinical Infectious …, 2024 - academic.oup.com
Abstract Background Hepatitis C virus (HCV) elimination requires treating people who use
drugs (PWUD), yet< 10% of PWUD in the United States access HCV treatment; access is …
drugs (PWUD), yet< 10% of PWUD in the United States access HCV treatment; access is …
[HTML][HTML] Peer outreach point-of-care testing as a bridge to hepatitis C care for people who inject drugs in Toronto, Canada
J Broad, K Mason, M Guyton, B Lettner… - International Journal of …, 2020 - Elsevier
Background People who inject drugs have high rates of hepatitis C (HCV) and yet many
remain undiagnosed and untreated. HCV treatment guidelines and elimination strategies …
remain undiagnosed and untreated. HCV treatment guidelines and elimination strategies …